Novo Nordisk Stock Falls After Ozempic Fails to Slow Alzheimer's
Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit weight-loss drugs didn't slow the progress of Alzheimer's disease.Novo Nordisk stock recently stood about 5.7% lower.The shares have
(The Wall Street Journal, 2025-11-24T19:50:56Z)